Neuropeptide release from airways of young and fully-grown rabbits

Pediatric Pulmonology

Volumn 41, Issue 12, 2006, Pages 1242-1249

  Larsen, Gary L ^a   Fratelli, Cori ^a   Loader, Joan ^a   Kang, June Ku Brian ^a   Dakhama, Azzeddine ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Airway development; Nerve growth factor; Neural maturation; Neuropeptides; Substance P; Vasoactive intestinal peptide

Indexed keywords

NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTROPHIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

AIRWAY; ANIMAL TISSUE; ARTICLE; ELECTROSTIMULATION; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; NERVE CELL DIFFERENTIATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RABBIT; REGULATORY MECHANISM; TRACHEA;

AGING; ANIMALS; FOLLOW-UP STUDIES; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH; NERVE GROWTH FACTOR; NEURONS; NEUROPEPTIDES; PHOTOMICROGRAPHY; PHYSICAL STIMULATION; RABBITS; SUBSTANCE P; TRACHEA; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33845414981     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20533     Document Type: Article

References (29)

1. Lewin GR, Barde YA. Physiology of neurotrophins. Ann Rev Neurosci 1996;19:289-317.
2. Nockher WA, Renz H. Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol 2006;117:583-589.
3. Hoyle GW, Graham RM, Finkelstein JB, Nguyen K-PT, Gozal D, Friedman M. Hyperinervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol 1998;18:149-157.
4. Braun A, Quarcoo D, Schulte-Herbruggen O, Lommatzsch M, Hoyle G, Renz H. Nerve growth factor induces airway hyperresponsiveness in mice. Int Arch Allergy Immunol 2001;124:205-207.
5. de Vries A, Dessing MC, Engels F, Henricks PAJ, Nijkamp F. Nerve growth factor induces a neurokinin-1 receptor mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999;159:1541-1544.
6. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, Shirato K. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995;151:613-617.
7. Grunstein MM, Tanaka DT, Grunstein JS. Mechanism of substance P-induced bronchoconstriction in maturing rabbit. J Appl Physiol: Respir Environ Exercise Physiol 1984;57:1238-1246.
8. Hislop AA, Wharton J, Allen KM, Polak JM, Haworth SG. Immunohistochemical localization of peptide-containing nerves in human airways: age-related changes. Am J Respir Cell Mol Biol 1990;3:191-198.
9. Colasurdo GN, Loader JE, Graves JP, Larsen GL. Modulation of acetylcholine release in rabbit airways in vitro. Am J Physiol 1995;268:L432-L437.
10. Gelfand AS, Larsen GL, Loader JE, Fan LL, Colasurdo GN. Effects of recurrent milk aspiration on neural control mechanisms in rabbit airways in vitro. Pediatr Pulmonol 1997;23:198-204.
11. Colasurdo GN, Loader JE, Graves JP, Larsen GL. Substance P-induced contraction of airway smooth muscle in young and adult rabbits. Effects of epithelium removal and neutral endopeptidase inhibition. Chest [Suppl] 1995;107:126S.
12. Larsen GL, Loader J, Nguyen DD, Colasurdo GN. Mechanisms of cholinergic dysfunction in rabbits following recurrent aspiration of cow's milk. Fed Pulmonol 2001;32:409-417.
13. Larsen GL, Loader J, Nguyen DD, Fratelli C, Dakhama A, Colasurdo GN. Mechanisms determining cholinergic neural responses in airways of young and mature rabbits. Ped Pulmonol 2004;38:97-106.
14. Dakhama A, Kanehiro A, Mäkelä MJ, Loader JE, Larsen GL, Gelfand EW. Regulation of airway hyperresponsiveness by calcitonin gene-related peptide in allergen sensitized and challenged mice. Am J Respir Crit Care Med 2002;165:1137-1144.
15. Virchow JC, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998;158:2002-2005.
16. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996;93:10955-10960.
17. Braun A, Appel E, Baruch R, Herz U, Botchkarev V, Paus R, Brodie C, Renz H. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998;28:3240-3251.
18. Chu HW, Kraft M, Krause JE, Rex MD, Martin RJ. Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 2000;106:713-722.
19. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and non-asthmatics. Eur Respir J 1991;4:673-682.
20. Corcoran BM. Distribution of calcitonin gene-related peptide, vasoactive intestinal polypeptide, neuropeptide Y, substance P, and dopamine beta-hydroxylase immunoreactive nerve fibers in the trachea of sheep. Res Vet Science 1996;60:69-75.
21. Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL. The significance of vasoactive intestinal peptide (VIP) in immunomodulation. Advances Neuroimmunol 1996;6:5-27.
22. Dey RD, Shannon WA, Said SI. Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats, and human subjects. Cell Tissue Res 1981;220:231-238.
23. Groneberg DA, Springer J, Fischer A. Vasoactive intestinal polypeptide as mediator of asthma. Pulmon Pharmacol Therap 2001;14:391-401.
24. Ollerenshaw S, Jarvis D, Woolcock AJ, Sullivan C, Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 1989;320:1244-1248.
25. Chanez P, Sprinall D, Vignola AM, Moradoghi-Hattvani A, Polak JM, Godard P, Bousquet J. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway disease. Am J Respir Crit Care Med 1998;158:985-990.
26. Howarth PH, Springall DR, Redington AE, Djukanovic R, Holgate ST, Polak JM. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am J Respir Cell Mol Biol 1995;13:288-296.
27. Geppetti P, De Rossi M, Mione MC, Renzi D, Amenta F. Age-related changes in vasoactive intestinal polypeptide levels and distribution in the rat lung. J Neural Trans 1988;74:1-10.
28. Luma J, Hintz K, Welliver R. The nonadrenergic, noncholinergic (NANC) nervous system in bronchiolitis: role of substance P (SP) and vasoactive intestinal peptide (VIP). Am J Respir Crit Care Med [Suppl] 2005;171:A832.
29. Cardell LO, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J 1994;7:2169-2173.